Status:
UNKNOWN
Artificial Intelligence Neuropathologist
Lead Sponsor:
Huashan Hospital
Collaborating Sponsors:
United Imaging Healthcare
Conditions:
CNS Tumor
Neuropathology
Eligibility:
All Genders
18-75 years
Brief Summary
CNS tumor requires biopsy for pathological diagnosis, which is known as the "golden standard". We would like to achieve automated classification of brain tumors based on deep learning in digital histo...
Detailed Description
The aim of the study is to develop an automated pathological diagnosis system for CNS tumors based on deep learning technique. It is designed to firstly develop the best deep learning model for pathol...
Eligibility Criteria
Inclusion
- The participants diagnosed with brain cancer by diagnosis of WHO 2016 classification of CNS tumors.
Exclusion
- Voluntarily quit
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05300113
Start Date
May 1 2022
End Date
December 1 2024
Last Update
March 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hushan Hospital, Fudan University
Shanghai, Shanghai Municipality, China, 200040